Impact of Platinum-based Cancer Treatment on Endothelial Function
NCT04681560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-12-23
Summary
In this research we investigate endothelial function in cancer patients who received platinum based chemotherapy.
Conditions
- High Blood Pressure
- Cardiovascular Complication
Sponsors & Collaborators
-
I.M. Sechenov First Moscow State Medical University
lead OTHER
Principal Investigators
-
Dmitry Shchekochikhin, PhD · I.M. Sechenov First Moscow State Medical University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-18
- Primary Completion
- 2019-12-09
- Completion
- 2020-01-20
Countries
- Russia
Study Locations
More Related Trials
-
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
NCT00637624 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00003742 ·Status: COMPLETED ·Phase: PHASE1
-
Intermediate and Long Term Vascular Effects of Cisplatin in Patients With Testicular Cancer
NCT03557164 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
NCT00354393 ·Status: COMPLETED ·Phase: PHASE2
-
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
NCT00055835 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer
NCT06591650 ·Status: RECRUITING ·Phase: PHASE2
-
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
NCT03364530 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
NCT00504192 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
NCT00601159 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction
NCT00006062 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00005068 ·Status: COMPLETED ·Phase: PHASE1
-
Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy
NCT05601479 ·Status: UNKNOWN ·Phase: PHASE2
-
Platinum Rechallenge in Patients With Platinum-sensitive mTNBC
NCT02607215 ·Status: UNKNOWN ·Phase: PHASE2
-
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
NCT01275612 ·Status: WITHDRAWN ·Phase: PHASE1
-
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
NCT01498289 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.
NCT02240017 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer
NCT01483300 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
NCT03724097 ·Status: UNKNOWN
-
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma
NCT00713687 ·Status: WITHDRAWN ·Phase: PHASE2
-
Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer
NCT03471468 ·Status: TERMINATED ·Phase: NA
-
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
NCT06298968 ·Status: RECRUITING ·Phase: PHASE2
-
Investigating Cardiovascular Adverse Events Related to Cancer Treatment
NCT03199300 ·Status: ACTIVE_NOT_RECRUITING
-
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00004242 ·Status: COMPLETED ·Phase: PHASE1
-
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00047047 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment
NCT01243632 ·Status: COMPLETED ·Phase: PHASE2